Gail J. Maderis founded Genzyme Molecular Oncology. Currently, she is President, Chief Executive Officer & Director at Antiva Biosciences, Inc.
She is also Member-Healthcare Initiative Board at Harvard Business School and on the board of 9 other companies.
Ms. Maderis previously held the position of Principal at Bain & Co., Inc., President & Chief Executive Officer for The Bay Area Bioscience Association, President & Chief Executive Officer of Five Prime Therapeutics, Inc., President for Genzyme Molecular Oncology and Vice President for Genzyme Corp.
Ms. Maderis received an undergraduate degree from the University of California, Berkeley and an MBA from Harvard Business School.